- Equipment
- Consumables
Immunosuppressant Drug Monitoring Market size was valued at USD x million in 2022 and is poised to grow at a CAGR of x% from 2023 - 2029. Immunosuppressant drug monitoring is most vital for monitoring of immunosuppressant drug levels in patients in order to prevent organ rejection. It is one of the applications of therapeutic drug monitoring, aims to maintain the adequate concentration of drugs in body fluids in order to refine patient care by adjusting individual drug dosage for better outcomes. Immunosuppressant drugs are known as anti-rejection drugs, which inhibit the activity of the immune system that are most commonly used in organ transplantations, autoimmune disorders like multiple sclerosis, rheumatoid arthritis, and chrons disease. Growing demand for organ transplantations, advancements in procedures of organ transplantation, and growing prevalence of autoimmune diseases are expected to witness tremendous growth of the immunosuppressant drug monitoring market. Furthermore, favorable reimbursement policies and growing awareness among the people regarding healthcare and organ transplantations are expected to fuel the immunosuppressant drug monitoring market. However, strict regulatory frameworks and the availability of alternative therapies like stem cell therapy for immunosuppression are expected to hamper the growth of the immunosuppressant drug monitoring market. Therapeutic drug monitoring is a method of determining the drug's safe and effective dosage. Therapeutic Drug Monitoring is a technique for treating and monitoring drug concentrations in body fluids, most often plasma. A major element driving the global market's growth is the growing demand for better healthcare facilities in developing countries to meet the needs of a growing urban population. Furthermore, the growing elderly population and the development of novel medication management systems, particularly in emerging nations, are two major drivers driving market expansion.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Immunosuppressant drug monitoring market is growing at a significant rate due to rise in prevalence of autoimmune disorders and organ transplantations. As per WHO statistics, about 119,873 organ transplantation cases were reported in 2014, raised about 1.8% from 2013. Growing prevalence of autoimmune disorders and rise in investments in R&D activities for innovation of new procedures are expected to propel the immunosuppressant drug monitoring market over the forecast timeframe. Moreover, acquisitions and mergers, new product approvals, and product launches are major strategies followed by market players for increasing the revenue in immunosuppressant drug monitoring market.
The immunosuppressant drug monitoring market size was valued at USD x million in 2022
The immunosuppressant drug monitoring market key players are: Thermo Fisher Scientific Hoffmann-La Roche AG Bio-Rad Laboratories Inc. Abbott Laboratories Siemens Healthcare Danaher Corporation
The immunosuppressant drug monitoring market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Immunosuppressant Drug Monitoring Market Introduction |
2.1.Global Immunosuppressant Drug Monitoring Market - Taxonomy |
2.2.Global Immunosuppressant Drug Monitoring Market - Definitions |
2.2.1.Product Type |
2.2.2.Technology |
2.2.3.Drugs |
2.2.4.End User |
2.2.5.Region |
3. Global Immunosuppressant Drug Monitoring Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID-19 on Market |
4. Global Immunosuppressant Drug Monitoring Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Immunosuppressant Drug Monitoring Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Equipment |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Consumables |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Immunosuppressant Drug Monitoring Market By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Proteomics Technologies |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Immunoassays |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Electrophoresis |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Spectrometry |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global Immunosuppressant Drug Monitoring Market By Drugs, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Antibodies |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Corticosteroids |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Calcineurin inhibitors |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Anti-proliferative agents |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. mTOR inhibitors |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Others |
7.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
8. Global Immunosuppressant Drug Monitoring Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Hospitals |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Diagnostic laboratories |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Research Institutes |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Academic Institutes |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global Immunosuppressant Drug Monitoring Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10. North America Immunosuppressant Drug Monitoring Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Equipment |
10.1.2.Consumables |
10.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Proteomics Technologies |
10.2.2.Immunoassays |
10.2.3.Electrophoresis |
10.2.4.Spectrometry |
10.3. Drugs Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Antibodies |
10.3.2.Corticosteroids |
10.3.3.Calcineurin inhibitors |
10.3.4.Anti-proliferative agents |
10.3.5.mTOR inhibitors |
10.3.6.Others |
10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals |
10.4.2.Diagnostic laboratories |
10.4.3.Research Institutes |
10.4.4.Academic Institutes |
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11. Europe Immunosuppressant Drug Monitoring Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Equipment |
11.1.2.Consumables |
11.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Proteomics Technologies |
11.2.2.Immunoassays |
11.2.3.Electrophoresis |
11.2.4.Spectrometry |
11.3. Drugs Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Antibodies |
11.3.2.Corticosteroids |
11.3.3.Calcineurin inhibitors |
11.3.4.Anti-proliferative agents |
11.3.5.mTOR inhibitors |
11.3.6.Others |
11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals |
11.4.2.Diagnostic laboratories |
11.4.3.Research Institutes |
11.4.4.Academic Institutes |
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12. Asia Pacific (APAC) Immunosuppressant Drug Monitoring Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Equipment |
12.1.2.Consumables |
12.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Proteomics Technologies |
12.2.2.Immunoassays |
12.2.3.Electrophoresis |
12.2.4.Spectrometry |
12.3. Drugs Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Antibodies |
12.3.2.Corticosteroids |
12.3.3.Calcineurin inhibitors |
12.3.4.Anti-proliferative agents |
12.3.5.mTOR inhibitors |
12.3.6.Others |
12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals |
12.4.2.Diagnostic laboratories |
12.4.3.Research Institutes |
12.4.4.Academic Institutes |
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13. Middle East and Africa (MEA) Immunosuppressant Drug Monitoring Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Equipment |
13.1.2.Consumables |
13.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Proteomics Technologies |
13.2.2.Immunoassays |
13.2.3.Electrophoresis |
13.2.4.Spectrometry |
13.3. Drugs Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Antibodies |
13.3.2.Corticosteroids |
13.3.3.Calcineurin inhibitors |
13.3.4.Anti-proliferative agents |
13.3.5.mTOR inhibitors |
13.3.6.Others |
13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals |
13.4.2.Diagnostic laboratories |
13.4.3.Research Institutes |
13.4.4.Academic Institutes |
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14. Latin America Immunosuppressant Drug Monitoring Market,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Equipment |
14.1.2.Consumables |
14.2. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Proteomics Technologies |
14.2.2.Immunoassays |
14.2.3.Electrophoresis |
14.2.4.Spectrometry |
14.3. Drugs Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Antibodies |
14.3.2.Corticosteroids |
14.3.3.Calcineurin inhibitors |
14.3.4.Anti-proliferative agents |
14.3.5.mTOR inhibitors |
14.3.6.Others |
14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals |
14.4.2.Diagnostic laboratories |
14.4.3.Research Institutes |
14.4.4.Academic Institutes |
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Thermo Fisher Scientific |
15.2.2.Hoffmann-La Roche AG |
15.2.3.Bio-Rad Laboratories Inc. |
15.2.4.Abbott Laboratories |
15.2.5.Siemens Healthcare |
15.2.6.Danaher Corporation |
16. Research Methodology |
17. Appendix and Abbreviations |